Sarah Cavanaugh Net Worth & Insider Trades
Sarah Cavanaugh - SVP OF CORP AFFAIRS & ADMIN., Celldex Therapeutics, Inc
What is Sarah Cavanaugh's Net Worth?
The current estimated net worth of Celldex Therapeutics, Inc's SVP OF CORP AFFAIRS & ADMIN., Sarah Cavanaugh, is estimated to be about $1.87M . Sarah Cavanaugh owns about 1,284 units of Celldex Therapeutics, Inc common stock. In the last 5 years at Celldex Therapeutics, Inc, Sarah Cavanaugh has sold an estimated value of $1.81M worth.
What is Sarah Cavanaugh's Past Insider Trading?
Sarah Cavanaugh's largest purchase order was 32,667 units , worth over $99.26K on August 19, 2022. Sarah Cavanaugh's largest sale order was 32,667 units , worth over $1.2M on August 19, 2022. In total, Sarah Cavanaugh has made about 10 transactions over 5 years of their time at Celldex Therapeutics, Inc. Sarah Cavanaugh usually trades in June, with the busiest year in 2021.
Sarah Cavanaugh
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
What is Sarah Cavanaugh's' Mailing Address?
- Mailing address is C/o Celldex Therapeutics, Inc. 53 Frontage Road, Suite 220 Hampton NJ 08827 NJ
Celldex Therapeutics, Inc Executive Compensation
Name |
Year
|
Other Earnings Plans or Compensations
|
Salary
|
Bonus
|
Stock Awards
|
Option Awards
|
Other Earnings Plans or Compensations
|
Change in Pension Value
|
Other Compensation
|
Total
|
|---|---|---|---|---|---|---|---|---|---|---|
| No matching records found | ||||||||||
Source: https://www.sec.gov/Archives/edgar/data/744218/000110465921055589/tm212386-1_def14a.htm
What are Celldex Therapeutics, Inc's Past Insider Trades?
Celldex Therapeutics, Inc's most recent insider trade came on December 9, 2022 by Tibor Keler who sold 16,860 units worth $622.61K . In the last 14 years, insiders at Celldex Therapeutics, Inc have sold an estimated value of $32.29M and bought an estimated value of $5.89M worth of shares. Insider trading is most common in June, with the busiest year in 2018. The most active traders at the company are Gerald McMahon, Director, Anthony S Marucci, PRESIDENT & CEO, and Avery W Catlin, Sr. VP & CFO .
Celldex Therapeutics, Inc. Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||